Clinical Trials Logo
  1. Home
  2. Inflammatory Arthritis
  3. NCT02144272

Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Inflammatory Arthritis Clinical Trial

Official title:
A Phase 1 Single-Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of LY3114062 in Subjects With Inflammatory Arthritis

Clinical Trial Summary

The main purpose of this study is to learn more about the safety of LY3114062 and to find out how well it is tolerated in participants with an inflammatory arthritis. The study will also investigate how the body processes the drug and how the drug affects inflammatory arthritis. The study is expected to last about 3 months.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02144272
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 1
Start date June 2014
Completion date June 2015
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04249817 - Keeping Stable Inflammatory Arthritis Patients in Their Communities With the Advanced Clinician Practitioner in Arthritis Care N/A
Not yet recruiting NCT06162195 - The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement N/A
Completed NCT01303874 - Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) Phase 4
Active, not recruiting NCT03343171 - Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
Recruiting NCT04426747 - Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis
Active, not recruiting NCT04956380 - Self-assessment Triage in Inflammatory Arthritis N/A
Active, not recruiting NCT02538757 - Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE) Phase 2
Completed NCT01874067 - C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
Completed NCT03140995 - Sleep and Exercise in Rheumatoid Arthritis N/A
Withdrawn NCT02027298 - Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study Phase 2
Recruiting NCT00512239 - Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
Terminated NCT03937856 - Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases N/A
Completed NCT02436785 - Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? N/A
Completed NCT02538341 - Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Phase 2
Completed NCT02465879 - Allied Health in Rheumatology Triage Project N/A
Completed NCT03672916 - Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty
Completed NCT04806867 - Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
Active, not recruiting NCT01307384 - Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
Terminated NCT03672370 - PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty
Not yet recruiting NCT05216757 - Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) Phase 2/Phase 3